Skip to content

ALLOS THERAPEUTICS INC

CIK 0001097264

← back to feed
Revenue (TTM)
$73.29M
+115.9% YoY Q2 Aug 2012
Net Income (TTM)
−$33.19M
+60.6% YoY Q2 Aug 2012
EPS Diluted (TTM)
—
Q2 Aug 2012
Gross Margin
—
Q2 Aug 2012
Operating Margin
-45.4%
Q2 Aug 2012
Net Margin
-45.3%
Q2 Aug 2012
Free Cash Flow (TTM)
—
Q2 Aug 2012
Cash
$87.56M
Q2 Aug 2012
Total Debt
—
Q2 Aug 2012
Shares Outstanding
106.98M sh
Q2 Aug 2012

Revenue & Net Income

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings